RE: interesting report on key players on PMEL market Scancell !26 Mar 2021 16:09
Just to save everybody's time, I've got hold of the 'sample' report and it is useless. What hasn't been redacted has been changed to Lorem Ipsum placeholder text, the charts are meaningless, and the chapters don't even match the contents page. Not sure I'd want to spend $30 on this, let alone $3,000.
That said, there may be some large pharmacos and institutional investors who will go for it and if so, the unredacted SCLP coverage can only be a good thing.
Have a good weekend all.